Clinical Features and Management of Lung Cancer During Pregnancy: A Narrative Review Based on Reported Cases

被引：3

作者：

Zhou, Jian Ping ^{[1
,2
]}

Wang, Yi ^{[1
,2
]}

Lin, Ying Ni ^{[1
,2
]}

Sun, Xian Wen ^{[1
,2
]}

Ding, Yong Jie ^{[1
,2
]}

Yan, Ya Ru ^{[1
,2
]}

Li, Ning ^{[1
,2
]}

Zhang, Liu ^{[1
,2
]}

Li, Qing Yun ^{[1
,2
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Resp & Crit Care Med, 197 Ruijin 2nd Rd, Shanghai, 200025, Peoples R China

[2] Shanghai Jiao Tong Univ, Sch Med, Inst Resp Dis, Shanghai, Peoples R China

来源：

WOMENS HEALTH REPORTS | 2023年 / 4卷 / 01期

基金：

中国国家自然科学基金;

关键词：

pregnancy; lung cancer; diagnosis; treatment; outcomes; CELL; ADENOCARCINOMA; ERLOTINIB; FETUS; CHEMOTHERAPY; METASTASIS; PATIENT; SAFETY; NSCLC;

D O I：

10.1089/whr.2023.0085

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

This review aims to provide a summary of the clinical characteristics and outcomes of lung cancer during pregnancy. A comprehensive literature search yielded 93 cases of lung cancer during pregnancy from 1953 to 2022, with an average maternal age of similar to 34 years old. The initial symptoms reported were often nonspecific, such as cough, dyspnea, and chest pain. Cancer-related treatments, including surgery, radiotherapy, chemotherapy, and tyrosine kinase inhibitors, have shown beneficial effects on maternal outcomes. A majority of the newborns were born without malformation or diseases, but extended follow-up remains necessary. Early diagnosis of lung cancer is imperative for reducing the risks of placental and fetal metastasis and enhancing overall survival.

引用

页码：544 / 550

页数：7

共 43 条

[1] Cancer During Pregnancy: How to Handle the Bioethical Dilemmas?-A Scoping Review With Paradigmatic Cases-Based Analysis [J].

Alpuim Costa, Diogo ;

Nobre, Jose Guilherme ;

de Almeida, Susana Baptista ;

Ferreira, Marisa Horta ;

Goncalves, Ines ;

Braga, Sofia ;

Pais, Diogo .

FRONTIERS IN ONCOLOGY, 2020, 10

[2]

[Anonymous], 1997, Chest, V112, p159S, DOI [10.1378/chest.112.3_Supplement.159S, DOI 10.1378/CHEST.112.3_SUPPLEMENT.159S]

[3] Carboplatin and Weekly Paclitaxel for the Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) During Pregnancy [J].

Azim, Hatem A., Jr. ;

Scarfone, Giovanna ;

Peccatori, Fedro A. .

JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) :559-560

[4]

BARR JS, 1953, J OBSTET GYN BRIT EM, V60, P895

[5] Use of tyrosine kinase inhibitors during pregnancy for oncogenic-driven advanced non-small cell lung carcinoma [J].

Boudy, Anne-Sophie ;

Grausz, Noemie ;

Selleret, Lise ;

Gligorov, Joseph ;

Thomassin-Naggara, Isabelle ;

Touboul, Cyril ;

Darai, Emile ;

Cadranel, Jacques .

LUNG CANCER, 2021, 161 :68-75

[6] Lung cancer in pregnancy: Report of nine cases from an international collaborative study [J].

Boussios, S. ;

Han, S. N. ;

Fruscio, R. ;

Halaska, M. J. ;

Ottevanger, P. B. ;

Peccatori, F. A. ;

Koubkova, L. ;

Pavlidis, N. ;

Amant, F. .

LUNG CANCER, 2013, 82 (03) :499-505

[7] Use of chemotherapy during human pregnancy [J].

Cardonick, E ;

Iacobucci, A .

LANCET ONCOLOGY, 2004, 5 (05) :283-291

[8] Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety [J].

Cordeiro, Christina N. ;

Gemignani, Mary L. .

OBSTETRICAL & GYNECOLOGICAL SURVEY, 2017, 72 (03) :184-193

[9]

Couzin-Frankel J, 2022, SCIENCE, V375, P1216, DOI 10.1126/science.adb2029

[10]

Crosby E, 2001, CAN J ANAESTH, V48, P575, DOI 10.1007/BF03016835

← 1 2 3 4 5 →